Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeNuVasive Inc.NuVasive Expands its Advanced Materials Science™ Portfolio

NuVasive Expands its Advanced Materials Science™ Portfolio

To Offer Porous Titanium Spine Implants for all TLIF Procedures

NuVasive, Inc. announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company’s Advanced Materials Science™ (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most commonly performed procedure in the spine industry.

The availability of Modulus TLIF-A further extends NuVasive’s technology offerings in the spinal deformity market given its differentiated ability to provide anterior column support, increase segmental lordosis and maximize capability to restore sagittal alignment. This solution increases the Company’s footprint in the U.S. interbody device market, which is estimated to be more than $1.2 billion, and extends its entire AMS portfolio to a global patient audience with significant market share in anteriorly placed TLIF implants.1 Furthermore, the system is designed to work seamlessly with the Company’s MAS® TLIF and MAS Midline access systems allowing customization options to specific surgical techniques.

“The Modulus TLIF-A system is the perfect synergy between optimized material properties and deliverability,” said Jeffrey L. Gum, MD, orthopedic surgeon at the Norton Leatherman Spine Center. “The lattice design allows for improved imaging characteristics, a prime environment to promote fusion and an ideal modulus of elasticity. Additionally, the system optimizes surgical workflow by utilizing a single instrument for implant insertion and articulation.”

Modulus TLIF-A is an anteriorly placed implant featuring a porous titanium surface technology that is designed to promote bone in-growth and bone on-growth. Animal studies also demonstrated stronger osseointegration than solid implants with smooth or rough surfaces.2-5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.

“This complete portfolio offering for the thoracolumbar posterior procedures space is yet another example of NuVasive’s commitment to deliver differentiated technology that supports better patient outcomes,” said Matt Link, president of NuVasive. “NuVasive’s implants are designed to combine the inherent benefits of porosity with the advantageous material properties of PEEK and titanium to create implants intelligently designed for fusion, which we believe out performs traditional and competitive implants in the market.”

In June, the company announced the launch of Modulus TLIF-O, integrating the Modulus technology with an implant designed with a lordosis cut in the oblique plane to maximize sagittal correction without introducing the undesired coronal deformity commonly seen with standard oblique implant offerings. With the availability of Modulus TLIF-A, the company plans to launch its comprehensive Advanced Materials Science TLIF portfolio in the global market later this year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy